<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01702116</url>
  </required_header>
  <id_info>
    <org_study_id>APR2011</org_study_id>
    <nct_id>NCT01702116</nct_id>
  </id_info>
  <brief_title>Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma</brief_title>
  <official_title>Multicenter Randomized Controlled Trial, Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stony Brook University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stony Brook University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study that compares two types of surgery for rectal cancer. There are two
      procedures that can be used during this surgery, conventional abdominal resection (APR) and
      extended (or extralevator) APR. The investigators are doing this research to see whether the
      extralevator APR increases the likelihood that the edge of the tissue that is removed will be
      more likely to be free from cancer cells compared with the conventional APR surgery. At this
      time there is no evidence that one type of procedure is better at this than the other. The
      objective of this research is to determine whether extralevator APR is more likely to have
      clean margins (free of cancer) compared to the standard APR surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">July 2013</completion_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>measurement of circumferential resection margin</measure>
    <time_frame>0-10 minutes post surgery</time_frame>
    <description>Measurement in millimeters (mm) of the circumferential resection margin.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>operative time</measure>
    <time_frame>4-6 hours</time_frame>
    <description>operative time from skin incision to skin closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital stay</measure>
    <time_frame>from beginning of surgery through discharge, usually 4-5 days</time_frame>
    <description>duration of hospital stay (defined as from beginning of surgery to time of discharge, measured in hours)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>estimated blood loss</measure>
    <time_frame>4-6 hours</time_frame>
    <description>estimated blood loss (ml) recorded by the anesthesiologist (not by the surgeon)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Rectal Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>extralevator APR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is a modified and more extensive procedure that is used to remove the levator muscle en bloc with the anal canal and the mesorectum, creating a more &quot;cylindrical&quot; specimen, so that the amount of tissue removed around the tumor will be larger, thereby reducing the probability that the CRM will be positive.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard APR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional abdominoperineal resection (APR)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>extralevator APR</intervention_name>
    <description>Extralevator Abdominoperineal Resection For Rectal Adenocarcinoma. The aim of this modified and more extensive procedure is to remove the levator muscle en bloc with the anal canal and the mesorectum, creating a more &quot;cylindrical&quot; specimen, so that the amount of tissue removed around the tumor will be larger, thereby reducing the probability that the CRM will be positive.</description>
    <arm_group_label>extralevator APR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>APR</intervention_name>
    <description>standard Abdominoperineal Resection For Rectal Adenocarcinoma</description>
    <arm_group_label>standard APR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resectable, histologically proven primary adenocarcinoma of the low rectum with
             internal and/or external sphincter muscle involvement. Staged as follows prior to
             neoadjuvant chemoradiation:

          -  Stage T3 or T4 at MRI

          -  N0-2 at MRI

          -  M0 at CT scan

          -  Patient must undergo long term neoadjuvant chemoradiation: 20 fractions of radiation
             over â‰¥5 weeks: total of 50-60 Gy, and chemotherapeutic agents

        Exclusion Criteria:

          -  Squamous cell carcinoma

          -  Adenocarcinoma Stage T1-2, any N

          -  T4 with one of the following:

        with pelvic side wall involvement requiring sacrectomy requiring prostatectomy (partial or
        total) Distant metastasis (M1) Unresectable primary rectal cancer or Inability to complete
        R0 resection. Recurrent rectal cancer Previous pelvic malignancy Inability to sign informed
        consent Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roberto Bergamaschi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stony Brook University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roberto Bergamaschi, MD, PhD</last_name>
    <phone>631-444-2704</phone>
    <email>rbergamaschi@notes.cc.sunysb.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eileen Finnin, RN</last_name>
    <phone>631-444-5454</phone>
    <email>efinnin@notes.cc.sunysb.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>State University Hospital Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794-8191</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Bergamaschi, MD, PhD</last_name>
      <phone>631-444-2704</phone>
      <email>rbergamaschi@notes.cc.sunysb.edu</email>
    </contact>
    <contact_backup>
      <last_name>Paula Denoya, MD</last_name>
      <phone>631-444-3431</phone>
      <email>pdenoya@notes.cc.sunysb.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Paula Denoya, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stony Broook University Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794-8191</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Bergamaschi, MD, PhD</last_name>
      <phone>631-444-2704</phone>
      <email>rbergamaschi@notes.cc.sunysb.edu</email>
    </contact>
    <contact_backup>
      <last_name>Paula Denoya, MD</last_name>
      <phone>631-444-3431</phone>
      <email>pdenoya@notes.cc.sunysb.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Paula Denoya, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kenneth Shroyer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Bergamaschi, MD, PhD</last_name>
      <phone>631-444-2704</phone>
      <email>rbergamaschi@notes.cc.sunysb.edu</email>
    </contact>
    <investigator>
      <last_name>Roberto Bergamaschi, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paula Denoya, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sami Khan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Meenakshi Singh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kenneth Shroyer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Bergamaschi, MD, PhD</last_name>
      <phone>631-444-2704</phone>
      <email>rbergamaschi@notes.cc.sunysb.edu</email>
    </contact>
    <investigator>
      <last_name>Roberto Bergamaschi, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paula Denoya, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sami Khan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Meenakshi Singh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2011</study_first_submitted>
  <study_first_submitted_qc>October 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2012</study_first_posted>
  <last_update_submitted>April 23, 2013</last_update_submitted>
  <last_update_submitted_qc>April 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stony Brook University</investigator_affiliation>
    <investigator_full_name>Roberto Bergamaschi</investigator_full_name>
    <investigator_title>Professor and Chief, Colon and Rectal Surgery</investigator_title>
  </responsible_party>
  <keyword>rectal adenocarcinoma</keyword>
  <keyword>Standard APR</keyword>
  <keyword>Extralevator APR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

